Pneumologie 2023; 77(S 01): S6
DOI: 10.1055/s-0043-1760880
DOI: 10.1055/s-0043-1760880
Abstracts
Assoziation von KRAS/STK11/KEAP1 Mutationen und Outcome in der POSEIDON Studie: Durvalumab+/− Tremelimumab+Chemotherapie beim metastasierten NSCLC (mNSCLC)
Authors
-
N Reinmuth
1 Asklepios Lung Clinic -
S Peters
2 Centre Hospitalier Universitaire Vaudois, Lausanne University -
B Cho
3 Yonsei Cancer Center -
A Luft
4 Leningrad Regional Clinical Hospital -
J Alatorre-Alexander
5 Health Pharma Professional Research -
S Geater
6 Prince of Songkla University -
S Kim
7 Asan Medical Center, University of Ulsan College of Medicine -
G Ursol
8 Acinus -
M Hussein
9 Florida Cancer Specialists – Sarah Cannon Research Institute -
F Lim
10 Queen Mary University of London -
C Yang
11 Chang Gung Memorial Hospital -
L Araujo
12 Instituto Nacional de Cancer-Inca -
H Saito
13 Kanagawa Cancer Center -
R Stewart
14 Astrazeneca -
Z Lai
14 Astrazeneca -
R Doake
14 Astrazeneca -
L Krug
14 Astrazeneca -
E Garon
15 David Geffen School of Medicine at Ucla -
T Mok
16 Chinese University of Hong Kong -
M Johnson
17 Sarah Cannon Research Institute, Tennessee Oncology, Pllc -
W Eberhardt
18 University Medicine Essen, West German Cancer Center
